Decompensated chagasic heart failure versus non-chagasic heart failure at a tertiary care hospital: Clinical characteristics and outcomes

Santos, Luiza Nauane Borges Azevedo dos; Rocha, Mário de Seixas; Oliveira, Eloina Nunes de; Moura, Carlos Antônio Gusmão de; Araujo, Ayslan Jorge Santos de; Gusmão, Ítalo Magalhães; Feitosa-Filho, Gilson Soares; Cruz, Constança Margarida Sampaio.
Rev. Assoc. Med. Bras. (1992) ; 63(1): 57-63, Jan. 2017. tab, graf
Artículo en Inglés | LILACS | ID: biblio-842518

Documentos relacionados

  1. Screening of at-risk blood donors for Chagas disease in non-endemic countries: Lessons from a 2-year experience in Tuscany, Italy.
  2. A cohort study of cardiac resynchronization therapy in patients with chronic Chagas cardiomyopathy.
  3. Chagas disease is associated with a worse prognosis at 1-year follow-up after implantable cardioverter-defibrillator for secondary prevention in heart failure patients.
  4. Incidence and Predictors of Progression to Chagas Cardiomyopathy: Long-Term Follow-Up of <i>Trypanosoma cruzi</i>-Seropositive Individuals.
  5. Chagas Cardiomyopathy: An Update of Current Clinical Knowledge and Management: A Scientific Statement From the American Heart Association.
  6. Diagnosis and Management of Chagas Cardiomyopathy in the United States.
  7. Decompensated chagasic heart failure versus non-chagasic heart failure at a tertiary care hospital: Clinical characteristics and outcomes.
  8. Deriving a parsimonious cardiac endpoint for use in epidemiological studies of Chagas disease: results from the Retrovirus Epidemiology Donor Study-II (REDS-II) cohort.
  9. Chagas Disease: Chronic Chagas Cardiomyopathy.
  10. The indeterminate form of human chronic Chagas' disease A clinical epidemiological review.